Leukaemia Inhibitory Factor (LIF) and Oncostatin M (OSM) high affinity binding require additional receptor subunits besides gp130 and gp190

Cytokine

Volumn 8, Issue 3, 1996, Pages 197-205

  Heymann, Dominique ^a   Godard, Anne ^a   Raher, Sylvie ^a   Bentouimou, Nadia ^a   Blanchard, Frédéric ^a   Chérel, Michel ^a   Hallet, Marie Martine ^a   Jacques, Yannick ^a,b  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b INSTITUT DE BIOLOGIE   (France)

Author keywords

CHO cells; Cross linking; LIF receptor; OSM receptor; Transfection

Indexed keywords

COMPLEMENTARY DNA; LEUKEMIA INHIBITORY FACTOR; ONCOSTATIN M; RECEPTOR SUBUNIT; CROSS LINKING REAGENT; CYTOKINE; CYTOKINE RECEPTOR; GLYCOPROTEIN GP 130; GROWTH INHIBITOR; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR RECEPTOR; LEUKEMIA INHIBITORY FACTOR RECEPTOR ALPHA; LIF PROTEIN, HUMAN; LIFR PROTEIN, HUMAN; LYMPHOKINE; OSM PROTEIN, HUMAN; PEPTIDE; RECOMBINANT PROTEIN;

ANIMAL CELL; ARTICLE; BINDING COMPETITION; CANCER CELL CULTURE; CHO CELL; CHORIOCARCINOMA; CONTROLLED STUDY; CROSS LINKING; DNA TRANSFECTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN QUATERNARY STRUCTURE; RECEPTOR AFFINITY; RECEPTOR BINDING; STOICHIOMETRY; ANIMAL; AUDIOVISUAL EQUIPMENT; CELL LINE; CHEMISTRY; DIMERIZATION; GENETIC TRANSFECTION; HAMSTER; KINETICS; MACROMOLECULE; METABOLISM;

ANIMALIA;

ANIMALS; BINDING, COMPETITIVE; CELL LINE; CHO CELLS; CRICETINAE; CROSS-LINKING REAGENTS; CYTOKINES; DIMERIZATION; GROWTH INHIBITORS; HUMANS; INTERLEUKIN-6; KINETICS; LEUKEMIA INHIBITORY FACTOR; LEUKEMIA INHIBITORY FACTOR RECEPTOR ALPHA SUBUNIT; LYMPHOKINES; MACROMOLECULAR SUBSTANCES; MODELS, STRUCTURAL; ONCOSTATIN M; PEPTIDES; RECEPTORS, CYTOKINE; RECEPTORS, ONCOSTATIN M; RECEPTORS, OSM-LIF; RECOMBINANT PROTEINS; TRANSFECTION;

EID: 0029657884     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1996.0028     Document Type: Article

References (31)

1. Kitamura T (1994) Multimeric Cytokine Receptors. Trends Endocrinol Metab 5:8-14.
2. Godard A, Gascan H, Naulet J, Peyrat MA, Jacques Y, Soulillou JP, Moreau JF (1988) Biochemical characterization and purification of HILDA, a human lymphokine active on eosinophils and bone marrow cells. Blood 71:1618-1623.
3. Anegon I, Moreau JF, Godard A, Hallet MM, Wong G, Jacques Y, Peyrat MA, Soulillou JP (1990) Production of human Interleukin for DA cells HILDA/Leukemia Inhibitory Factor LIF by activated monocytes. Cell Immunol 130:50-65.
4. Malik N, Kallestad JC, Gunderson NL, Austin SC, Neubauer MG, Och V, Marquardt H, Zarling JM, Shobay M, Wei CM, Linsley PS, Rose TM (1989) Molecular cloning, sequence analysis and functional expression of a novel growth regulator: Oncostatin M. Mol Cell Biol 9:2847-2853.
5. Brown TJ, Lioubin MN, Marquardt H (1987) Purification and characterization of cytostatic lymphocytes produced by activated human T-lymphocytes: synergistic antiproliferative activily of transforming growth factor β1, interferon γ and oncostatin M for human melanoma cells. J Immunol 139:2977-2983.
6. Rose TM, Bruce AG (1991) Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony-stimulating factor, and interleukin 6. Proc Natl Acad Sci USA 88:8641-8645.
7. Nicola NA, Cross B, Simpson RJ (1993) The disulfidc bond arrangement of leukemia inhibitory factor: homology to oncostatin M and structural implications. Biochem Biophys Res Comm 190:20-26.
8. Sutherland GR, Baker E, Hyland VJ, Callen DF, Stahl J, Gough NM (1989) The gene for human leukemia inhibitory factor (LIF) maps to 22q 12. Leukemia 3:9-13.
9. Gearing DP (1993) The leukemia inhibitory factor and its receptor. Adv Immunol 53:31-58.
10. Godard A, Heymann D, Raher S, Anegon I, Peyrat MA, Le Mauff B, Mouray E, Gregoire M, Virdee K, Soulillou JP, Moreau JF, Jacques Y (1992) High and low affinity receptors for human interleukin for DA cells/leukemia inhibitory factor on human cells. Molecular characterization and cellular distribution. J Biol Chem 267:3214-3222.
11. Gearing DP, Thut CJ, VandeBos T, Gimpel SD, Delaney PB, King J, Price V, Cosman D, Beckmann MP (1991) Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130. EMBO J 10:2839-48.
12. Hibi M, Murakami M, Saito M, Hirano T, Taga T, Kishimoto T (1990) Molecular cloning and expression of an IL-6 signal transducer, gp 130. Cell 63:1149-1157.
13. Gearing DP, Comeau MR, Friend DJ, Gimpel SD, Thut CJ, McGourty J, Brasher KK, King JA (1992) The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor. Science 255:1434-1437.
14. Linsley PS, Bolton-Hanson M, Horn D, Malik N, Kallestad JC, Ochs V, Zarling JM, Shoyab M (1989) Identification and characterization of cellular receptors for the growth regulator, Oncostatin M. J Biol Chem 264:4282-4289.
15. Horn D, Fitzpatrick WC, Gompper PT, Ochs V, Bolton-Hanson M, Zarling JM, Malik N, Todaro GJ, Linsley PS (1990) Regulation of cell growth by recombinant Oncostatin. Growth Factors 2:157-165.
16. Liu J, Modrell B, Aruffo A, Marken JS, Taga T, Yasukawa K, Murakami M, Kishimoto T, Shoyab M (1992) Interleukin-6 signal transducer gp130 mediates oncostatin M signaling. J Biol Chem 267:16763-16766.
17. Sporeno E, Paonessa G, Salvati AL, Graziani R, Delmastro P, Ciliberto G, Toniatti C (1994) Oncostatin M binds directly to gp130 and behaves as interleukin-6 antagonist on a cell line expressing gp130 but lacking functional oncostatin M receptors. J Biol Chem 269:10991-10995.
18. Gearing DP, Bruce AG (1992) Oncostatin M binds the high-affinity leukemia inhibitory factor receptor. New Biol 4:61-5.
19. Thoma B, Bird TA, Friend DJ, Gearing DP, Dower SK (1994) Oncostatin M and leukemia inhibitory factor trigger overlapping and different signals through partially shared receptor complexes. J Biol Chem 269:6215-6222.
20. Gearing DP, Ziegler SF, Comeau MR, Friend D, Thoma B, Cosman D, Park L, Mosley B (1994) Proliferative responses and binding properties of hematopoietic cells transfected with low-affinity receptors for leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor. Proc Natl Acad Sci USA 91:1119-1123.
21. Stahl N, Yancopoulos GD (1993) The alphas, betas and kinases of cytokine receptor complexes. Cell 74:587-590.
22. Taga T, Kishimoto T (1992) Cytokine receptors and signal transduction. FASEB J 6:3387-3396.
23. Yamasaki K, Taga T, Hirato H, Kawanishi H, Seed B, Taniguchi T, Hirano T, Kishimoto T (1988) Cloning and expression of the human Interleukin-6 (BSF2/IFNbeta2) Receptor. Science 241:825-828.
24. Davis S, Aldrich TH, Valenzuela DM, Wong VV, Furth ME, Squinto SP, Yancopoulos GD (1991) The receptor for Ciliary Neurotrophic Factor. Science 260:59-63.
25. Hilton DJ, Hilton AA, Raicevic A, Rakar S, Harrison-Smith M, Gough NM, Begley CG, Metcalf D, Nicola NA, Willson TA (1994) Cloning of a murine IL-11 receptor alpha-chain; requirement for gp130 for high affinity binding and signal transduction. EMBO J 13:4765-4775.
26. Chérel M, Sorel M, Lebeau B, Dubois S, Moreau JF, Bataille R, Minvielle S, Jacques Y (1995) Molecular cloning of two isoforms of a receptor for the human haematopoietic cytokine interleukin-11. Blood 86:2534-2540.
27. Urlaub G, Chasin LA (1980) Isolation of Chinese hamster cell mutants deficient in dihydrofolate reductase activity. Proc Natl Acad Sci USA 77:4216-4220.
28. Matrisian LN, Bowden GT, Krieg P, Fürstenberger G, Briand JP, Leroy P, Breathnach R (1986) The mRNA coding for the secreted protease transin is expressed more abundantly in malignant than in benign tumors. Proc Natl Acad Sci USA 83:9413-9417.
29. Sambrook J, Fitsch EF, Maniatis T (1989) Molecular cloning: A laboratory manual. Cold Spring Harbor Press, New York.
30. Vie H, Gauthier T, Breathnach R, Bonneville M, Godard A, Dietrich J, Karam G, Gesnel MC, Peyrat MA, Jacques Y, Soulillou JP (1992) Human fusion protein between IL-2 and IgM heavy chain are cytotoxic for cells expressing the IL-2 receptor. Proc Natl Acad Sci USA 83:11337-11341.
31. Tejedor F, Ballesta JPG (1982) Iodination of biological samples without loss of functional activity. Anal Biochem 127:143-149.